For therapy of infections caused by KPC producers, combinations of beta-lactams with new beta-lactamase inhibitors, such as ceftazidime–avibactam, meropenem–vaborbactam, or imipenem–relebactam, or a new cefalosporin, cefiderocol, are suggested [45]. This evidence concerns the gene LACTB and infection.